• Mass Innovation Labs Host Space for Growing Biotech

    Bio-IT World “Something that the industry doesn’t really talk about is the cost of doing research,” says Amrit Chaudhuri, CEO of Mass Innovation Labs in Cambridge, Mass. Running a lab can cost hundreds of dollars per square foot, Chaudhuri says, but Mass Innovation Labs offers an alternative.

    Aug 18, 2016

  • Lies damn lies and CRISPR the legal battle escalates

    STAT | The gloves are off in the legal fight over CRISPR genome editing patents, as the latest documents filed in the case make clear.

    Aug 18, 2016

  • ExAC Project Pins Down Rare Gene Variants

    Nature News & Comment | Catalogue of genetic information from some 60,000 people reveals unexpected surprises - and highlights the need to make genomic data publicly accessible to aid studies of rare diseases.

    Aug 17, 2016

  • ARM pact Will Help Intel Woo Apple Into New Chip Deal

    Computerworld | The chances of Apple's using Intel's factories to have its iPhone and iPad chips made have just rocketed up.

    Aug 17, 2016

  • Spiking genomic databases with misinformation could protect patient privacy

    Nature News & Comment | Technique that adds noise to genetic data would enable much faster access to large data sets.

    Aug 16, 2016

  • Why CRISPR Is An Attractive Approach To Treat Sickle Cell Disease

    Forbes | Researchers describe a new way to use CRISPR editing to fix sickle cell disease, a debilitating genetic blood disorder.

    Aug 16, 2016

  • Ayar Labs Gets $2.5M to Go After Optical Chips for Data Centers

    Xconomy | This startup sits at the intersection of electronics, optics, energy efficiency, and the Internet. Ayar Labs is working on how to make data centers perform better with less energy.

    Aug 16, 2016

  • Beyond CRISPR: A Guide to the Many Other Ways to Edit a Genome

    Nature News | The surge of activity in recent years around CRISPR-Cas9 gene editing has also led to a flurry of modified CRISPR systems, or new systems entirely, which are starting to solve problems like delivering enzymes into cells, making specific changes to the DNA sequence, and editing RNA as well as DNA.

    Aug 11, 2016

  • Intel Buys Deep-Learning Startup Nervana to Bolster Machine Learning Chops

    Computerworld | Intel is buying Nervana Systems, a deep learning startup based out of California. The deal speaks volumes about Intel's hopes for the future and where the company is going.

    Aug 10, 2016

  • Broad's GATK Dominates as Genomics Go-To

    Bio-IT World | As the Genome Analysis Toolkit, developed at the Broad Institute, continues to serve as the standby for parsing raw genomic data in public projects and major institutions, members of the Broad speak to Bio-IT World about forthcoming updates in GATK4 and new ventures incorporating the toolkit.

    Aug 10, 2016

  • Google, Stanford Medicine Team Up on Genomics

    Fast Company | The school will adopt the Google Genomics cloud platform to improve how it treats patients with cancer, as well as to diagnose children with mysterious, rare diseases.

    Aug 9, 2016

  • Repositive Launches Patient Derived Xenographs Database

    Bio-IT World | Software company Repositive aims to make PDX mice, crucial animal models for studying human-like cancers, searchable across vendors by indexing hundreds of different repositories in one platform.

    Aug 8, 2016

  • Cray stock drops 30% as CEO says supercomputer market is slowing

    The Seattle Times | Cray CEO Peter Ungaro considers the slowdown in the supercomputer market as "temporary."

    Aug 4, 2016

  • Recommended Summer Reading For Biotech And Pharmaceutical Pros

    Forbes | Biotech and pharmaceutical industry professionals are busy people like everyone else. But they still find time to read books, especially when schedules slow down a tad during summer. So what are biotech professionals reading, and recommending, these days?

    Aug 3, 2016

  • Editas, MGH Announce Exclusive Licensing Agreement

    Bio-IT World Briefs | Editas Medicine and Massachusetts General Hospital (MGH) announced an exclusive licensing agreement this morning, under which Editas can access intellectual property and technology related to high-fidelity Cas9 nucleases and Cas9 PAM variants that will enable the company to address an expanded range of genetically-defined diseases with the potential for enhanced specificity.

    Aug 3, 2016

  • Legal Confusion Threatens to Slow Data Science

    Nature News & Comment | Daniel Himmelstein built a free online network to meld data from 28 public sources on links between drugs, genes, and diseases. Then he spent months chasing legal permission to republish the online data sets.

    Aug 3, 2016

  • Biogen Draws Takeover Interest from Rival Drugmakers

    WSJ | Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and Allergan PLC, raising the possibility of another huge deal in the health-care industry.

    Aug 2, 2016

  • Setting the Body’s ‘Serial Killers’ Loose on Cancer

    The New York Times | After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.

    Aug 2, 2016

  • Q&A Glaxo Exec Says Bioelectronics Is Not Science Fiction

    STAT | Glaxo and Verily Life Sciences will invest $715 million in Galvani Bioelectronics and hope to win approval for their implantable devices in several years.

    Aug 1, 2016

  • Data Management, New NGS Panels: News and Briefs

    Bio-IT World Briefs | News and product launches from bio IT, clinical IT, and diagnostics technologies include data management installation at Scripps Research Institute and new NGS panels for detection of extremely rare (low-frequency) mutations.

    Aug 1, 2016